HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jing Jin Selected Research

Zj6413

5/2016Poly (ADP-ribose) polymerases inhibitor, Zj6413, as a potential therapeutic agent against breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jing Jin Research Topics

Disease

148Neoplasms (Cancer)
06/2022 - 10/2002
33Breast Neoplasms (Breast Cancer)
11/2021 - 07/2006
32Inflammation (Inflammations)
10/2022 - 08/2010
31Infections
05/2022 - 06/2002
27Rectal Neoplasms (Rectal Cancer)
04/2022 - 10/2005
25Stomach Neoplasms (Stomach Cancer)
02/2022 - 05/2013
19Neoplasm Metastasis (Metastasis)
02/2022 - 03/2007
15Lung Neoplasms (Lung Cancer)
01/2022 - 02/2009
14Malaria
10/2022 - 11/2014
14Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 11/2006
13Carcinogenesis
04/2022 - 08/2005
12Carcinoma (Carcinomatosis)
04/2021 - 09/2007
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2013
11T-Cell Lymphoma (Lymphoma, T Cell)
12/2013 - 01/2006
10COVID-19
06/2022 - 01/2020
10Fibrosis (Cirrhosis)
05/2022 - 06/2011
10Ischemic Stroke
01/2022 - 05/2013
10Hepatocellular Carcinoma (Hepatoma)
02/2019 - 12/2002
9Glioblastoma (Glioblastoma Multiforme)
02/2022 - 01/2017
9Stroke (Strokes)
01/2022 - 01/2016
8Esophageal Neoplasms (Esophageal Cancer)
01/2022 - 10/2004
8Insulin Resistance
01/2022 - 01/2014
8Body Weight (Weight, Body)
11/2021 - 06/2013
8Lymphoma (Lymphomas)
01/2016 - 01/2006
7Huntington Disease (Huntington's Disease)
11/2021 - 07/2012
6Adenocarcinoma
05/2022 - 12/2004
6Fatigue
05/2022 - 11/2008
6Heart Failure
05/2022 - 10/2006
6Sarcoma (Soft Tissue Sarcoma)
04/2022 - 04/2007
6Colitis
03/2022 - 01/2016
6Hypoxia (Hypoxemia)
01/2022 - 09/2013
6Virus Diseases (Viral Diseases)
01/2022 - 06/2002
6Hemorrhage
01/2022 - 08/2016
6Liver Diseases (Liver Disease)
10/2021 - 12/2005
6Disease Progression
08/2021 - 10/2004
6Thrombosis (Thrombus)
03/2021 - 07/2016
5Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 06/2015
5Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2022 - 07/2014
5Liver Neoplasms (Liver Cancer)
11/2021 - 11/2014
5Hypertension (High Blood Pressure)
01/2021 - 05/2010
5Urinary Bladder Neoplasms (Bladder Cancer)
08/2020 - 01/2015
5Reperfusion Injury
03/2020 - 01/2016
5Asthma (Bronchial Asthma)
01/2019 - 08/2004

Drug/Important Bio-Agent (IBA)

64Proteins (Proteins, Gene)FDA Link
10/2022 - 05/2004
33Pharmaceutical PreparationsIBA
10/2022 - 10/2004
28Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2010
18Messenger RNA (mRNA)IBA
07/2022 - 03/2007
16DNA (Deoxyribonucleic Acid)IBA
04/2022 - 06/2002
15Biological ProductsIBA
01/2022 - 09/2013
14VaccinesIBA
10/2022 - 01/2015
12AntibodiesIBA
06/2022 - 08/2012
11CytokinesIBA
06/2022 - 05/2008
11Therapeutic UsesIBA
05/2022 - 01/2008
11RNA (Ribonucleic Acid)IBA
01/2022 - 07/2006
11Small Interfering RNA (siRNA)IBA
01/2022 - 10/2010
11Capecitabine (Xeloda)FDA Link
01/2022 - 03/2006
11Long Noncoding RNAIBA
11/2021 - 05/2016
11MicroRNAs (MicroRNA)IBA
12/2020 - 11/2012
10Glucose (Dextrose)FDA LinkGeneric
06/2020 - 01/2008
9AntioxidantsIBA
01/2022 - 01/2014
9EnzymesIBA
01/2022 - 07/2008
9AntigensIBA
01/2020 - 06/2013
8Carrier Proteins (Binding Protein)IBA
05/2022 - 09/2015
7Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 02/2005
7Interleukin-10 (Interleukin 10)IBA
11/2021 - 11/2011
7Cisplatin (Platino)FDA LinkGeneric
10/2021 - 01/2015
72- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA
06/2021 - 06/2014
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2020 - 01/2013
6Immunoglobulin G (IgG)IBA
01/2022 - 10/2012
6LigandsIBA
01/2022 - 04/2013
6Clopidogrel (Plavix)FDA Link
03/2021 - 01/2015
5Retinaldehyde (Retinal)IBA
01/2022 - 01/2018
5Neuroprotective AgentsIBA
01/2022 - 05/2013
5ErbB Receptors (EGF Receptor)IBA
01/2022 - 10/2006
5Antiviral Agents (Antivirals)IBA
01/2022 - 03/2016
5ZincIBA
01/2022 - 01/2016
5Anti-Bacterial Agents (Antibiotics)IBA
12/2021 - 06/2010
5Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2021 - 11/2008
5Insulin (Novolin)FDA Link
01/2021 - 01/2014
5Triglycerides (Triacylglycerol)IBA
01/2021 - 05/2010
5Amino AcidsFDA Link
06/2020 - 08/2008
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 04/2007
5Neutralizing AntibodiesIBA
01/2020 - 12/2015
5Sphingosine-1-Phosphate ReceptorsIBA
01/2019 - 07/2014
4LipidsIBA
09/2022 - 07/2015
4Interleukin-17 (Interleukin 17)IBA
05/2022 - 01/2018
4Interleukin-6 (Interleukin 6)IBA
05/2022 - 01/2020

Therapy/Procedure

68Radiotherapy
02/2022 - 10/2002
52Therapeutics
05/2022 - 10/2004
27Drug Therapy (Chemotherapy)
01/2022 - 03/2005
22Chemoradiotherapy
01/2022 - 10/2004
19Neoadjuvant Therapy
04/2022 - 10/2004
15Immunotherapy
06/2022 - 01/2020
11Mastectomy (Mammectomy)
11/2021 - 11/2009
10Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
10/2021 - 03/2012
8Aftercare (After-Treatment)
01/2022 - 03/2005
7Oral Administration
02/2022 - 01/2008
7Adjuvant Chemotherapy
08/2021 - 10/2005
6Segmental Mastectomy (Lumpectomy)
01/2021 - 09/2014
5Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 11/2008